Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

NCT04528927 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped \- Interest in the use of HCQ is controversial.

Conditions

COVID 19
Patients Hospitalized

Interventions

DRUG: HCQ
DRUG: Azithromycin
DRUG: Doxycycline
DIETARY_SUPPLEMENT: Zinc

Sponsor

Abderrahmane Mami Hospital

Collaborators

[object Object]
[object Object]